Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Clinical trial NCT07719894 · RECRUITING

Trial details

NCT number: NCT07719894
Sponsor: Seoul National University Bundang Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Atherosclerosis

Start date: 2026-05-06
Primary completion: 2028-12-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.